1. Home
  2. VTAK vs CWD Comparison

VTAK vs CWD Comparison

Compare VTAK & CWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTAK
  • CWD
  • Stock Information
  • Founded
  • VTAK 2002
  • CWD 2009
  • Country
  • VTAK United States
  • CWD United States
  • Employees
  • VTAK N/A
  • CWD N/A
  • Industry
  • VTAK Medical/Dental Instruments
  • CWD Real Estate
  • Sector
  • VTAK Health Care
  • CWD Finance
  • Exchange
  • VTAK Nasdaq
  • CWD Nasdaq
  • Market Cap
  • VTAK 4.1M
  • CWD 4.5M
  • IPO Year
  • VTAK 2018
  • CWD 2023
  • Fundamental
  • Price
  • VTAK $2.23
  • CWD $2.99
  • Analyst Decision
  • VTAK
  • CWD
  • Analyst Count
  • VTAK 0
  • CWD 0
  • Target Price
  • VTAK N/A
  • CWD N/A
  • AVG Volume (30 Days)
  • VTAK 36.6K
  • CWD 147.4K
  • Earning Date
  • VTAK 11-14-2025
  • CWD 11-13-2025
  • Dividend Yield
  • VTAK N/A
  • CWD N/A
  • EPS Growth
  • VTAK N/A
  • CWD N/A
  • EPS
  • VTAK N/A
  • CWD N/A
  • Revenue
  • VTAK $600,000.00
  • CWD $32,323,000.00
  • Revenue This Year
  • VTAK $822.86
  • CWD N/A
  • Revenue Next Year
  • VTAK $168.42
  • CWD $56.47
  • P/E Ratio
  • VTAK N/A
  • CWD N/A
  • Revenue Growth
  • VTAK 37.62
  • CWD N/A
  • 52 Week Low
  • VTAK $2.13
  • CWD $1.63
  • 52 Week High
  • VTAK $15.68
  • CWD $48.00
  • Technical
  • Relative Strength Index (RSI)
  • VTAK 44.41
  • CWD 40.26
  • Support Level
  • VTAK $2.13
  • CWD $2.82
  • Resistance Level
  • VTAK $2.56
  • CWD $3.02
  • Average True Range (ATR)
  • VTAK 0.12
  • CWD 0.18
  • MACD
  • VTAK -0.04
  • CWD 0.05
  • Stochastic Oscillator
  • VTAK 33.67
  • CWD 52.94

About VTAK Catheter Precision Inc.

Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.

About CWD CaliberCos Inc.

CaliberCos Inc is an asset management firm whose primary goal is to enhance the wealth of investors seeking to make investments in middle-market assets. The company's funds include investment vehicles focused on real estate, private equity, and debt facilities. The company earns asset management fees calculated as a percentage of managed capital in funds and offerings. The company markets services through direct sales to private investors, wholesaling to investment advisers, direct sales to family offices and institutions and through in-house client services. The company operates into three reportable segments: Fund Management, Development, and Brokerage. The majority of revenue is derived from the fund management fees segment.

Share on Social Networks: